Search

Your search keyword '"Molina-Van den Bosch, Mireia"' showing total 8 results
Start Over Author "Molina-Van den Bosch, Mireia"
8 results on '"Molina-Van den Bosch, Mireia"'

1. The membrane-associated protein 17 (MAP17) is up-regulated in response to empagliflozin on top of RAS blockade in experimental diabetic nephropathy

Author

Vergara, Ander, primary, Llorens-Cebrià, Carmen, additional, Martos, Nerea, additional, Martínez-Díaz, Irene, additional, Stein, Frank, additional, Domínguez-Báez, Pamela, additional, Molina-Van den Bosch, Mireia, additional, Rettel, Mandy, additional, Benito, Begoña, additional, Bermejo, Sheila, additional, Pieper, Michael Paul, additional, Jacobs-Cachá, Conxita, additional, and Soler, Maria José, additional

Published
2023
Full Text
View/download PDF

2. MO005: RPTEC/TERT1 Cells Cultured in Monolayer are not Suitable for Assessing Apolipoprotein A-I uptake due to the Lack of Cubilin–Amnionless (CUBAM) Complex

Author

Llorens Cebrià, Carmen, primary, Durán, Monica, additional, Molina Van den Bosch, Mireia, additional, Dominguez, Pamela, additional, Villena, Yolanda, additional, Cantero Recasens, Gerard, additional, José Soler Romeo, Maria, additional, Hellín, Joan López, additional, and Jacobs Cachá, Conxita, additional

Published
2022
Full Text
View/download PDF

5. The Impact of Age on Mortality in Chronic Haemodialysis Population with COVID-19

Author

Vergara, Ander, primary, Molina-Van den Bosch, Mireia, additional, Toapanta, Néstor, additional, Villegas, Andrés, additional, Sánchez-Cámara, Luis, additional, Sequera, Patricia, additional, Manrique, Joaquín, additional, Shabaka, Amir, additional, Aragoncillo, Inés, additional, Ruiz, María, additional, Benito, Silvia, additional, Sánchez, Emilio, additional, and Soler, María, additional

Published
2021
Full Text
View/download PDF

8. The Impact of Age on Mortality in Chronic Haemodialysis Popu-Lation with COVID-19.

Author

Vergara A, Molina-Van den Bosch M, Toapanta N, Villegas A, Sánchez-Cámara L, Sequera P, Manrique J, Shabaka A, Aragoncillo I, Ruiz MC, Benito S, Sánchez E, and Soler MJ

Abstract

Age and chronic kidney disease have been described as mortality risk factors for coronavirus disease 2019 (COVID-19). Currently, an important percentage of patients in haemodialysis are elderly. Herein, we investigated the impact of age on mortality among haemodialysis patients with COVID-19. Data was obtained from the Spanish COVID-19 chronic kidney disease (CKD) Working Group Registry. From 18 March 2020 to 27 August 2020, 930 patients on haemodialysis affected by COVID-19 were included in the Registry. A total of 254 patients were under 65 years old and 676 were 65 years or older (elderly group). Mortality was 25.1% higher (95% CI: 22.2-28.0%) in the elderly as compared to the non-elderly group. Death from COVID-19 was increased 6.2-fold in haemodialysis patients as compared to the mortality in the general population in a similar time frame. In the multivariate Cox regression analysis, age (hazard ratio (HR) 1.59, 95% CI: 1.31-1.93), dyspnea at presentation (HR 1.51, 95% CI: 1.11-2.04), pneumonia (HR 1.74, 95% CI: 1.10-2.73) and admission to hospital (HR 4.00, 95% CI: 1.83-8.70) were identified as independent mortality risk factors in the elderly haemodialysis population. Treatment with glucocorticoids reduced the risk of death (HR 0.68, 95% CI: 0.48-0.96). In conclusion, mortality is dramatically increased in elderly haemodialysis patients with COVID-19. Our results suggest that this high risk population should be prioritized in terms of protection and vaccination.

Published
2021
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results